Compare CRC & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRC | HAE |
|---|---|---|
| Founded | 2014 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 2020 | 1996 |
| Metric | CRC | HAE |
|---|---|---|
| Price | $46.98 | $121.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | $74.08 | ★ $147.18 |
| AVG Volume (30 Days) | ★ 887.3K | 591.2K |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.72 |
| Revenue | ★ $3,669,000,000.00 | $910,373,000.00 |
| Revenue This Year | $2.35 | $8.17 |
| Revenue Next Year | N/A | $10.82 |
| P/E Ratio | ★ N/A | $71.52 |
| Revenue Growth | ★ 14.73 | N/A |
| 52 Week Low | $43.25 | $51.00 |
| 52 Week High | $71.98 | $132.00 |
| Indicator | CRC | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 34.08 | 55.70 |
| Support Level | $45.45 | $115.49 |
| Resistance Level | $55.21 | $122.84 |
| Average True Range (ATR) | 1.94 | 4.60 |
| MACD | -0.38 | -0.42 |
| Stochastic Oscillator | 15.02 | 31.72 |
California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.